258 related articles for article (PubMed ID: 29466249)
1. Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2018 Feb; 10(2):229-240. PubMed ID: 29466249
[TBL] [Abstract][Full Text] [Related]
2. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
Front Oncol; 2019; 9():615. PubMed ID: 31440463
[TBL] [Abstract][Full Text] [Related]
3. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
Fiorillo M; Tóth F; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
[TBL] [Abstract][Full Text] [Related]
5. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
6. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).
Fiorillo M; Lamb R; Tanowitz HB; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Aging (Albany NY); 2016 Aug; 8(8):1593-607. PubMed ID: 27344270
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride.
Rideout D; Bustamante A; Patel J
Int J Cancer; 1994 Apr; 57(2):247-53. PubMed ID: 8157363
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.
Schibler J; Tomanek-Chalkley AM; Reedy JL; Zhan F; Spitz DR; Schultz MK; Goel A
PLoS One; 2016; 11(11):e0167323. PubMed ID: 27902770
[TBL] [Abstract][Full Text] [Related]
9. MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity
Sargiacomo C; Stonehouse S; Moftakhar Z; Sotgia F; Lisanti MP
Front Oncol; 2021; 11():678343. PubMed ID: 34395247
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
11. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
12. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production.
Fiorillo M; Tóth F; Brindisi M; Sotgia F; Lisanti MP
Cells; 2020 Jun; 9(6):. PubMed ID: 32585919
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel thiazole-derivatives as mitochondrial targeting inhibitors of cancer cells.
Dang X; Lei S; Luo S; Hu Y; Wang J; Zhang D; Lu D; Jiang F; Fu L
Bioorg Chem; 2021 Sep; 114():105015. PubMed ID: 34139611
[TBL] [Abstract][Full Text] [Related]
14. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
[TBL] [Abstract][Full Text] [Related]
15. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
17. Enabling Mitochondrial Uptake of Lipophilic Dications Using Methylated Triphenylphosphonium Moieties.
Ong HC; Hu Z; Coimbra JTS; Ramos MJ; Kon OL; Xing B; Yeow EKL; Fernandes PA; García F
Inorg Chem; 2019 Jul; 58(13):8293-8299. PubMed ID: 31184865
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening identifies artesunate as selective inhibitor of cancer stemness: Involvement of mitochondrial metabolism.
Subedi A; Futamura Y; Nishi M; Ryo A; Watanabe N; Osada H
Biochem Biophys Res Commun; 2016 Sep; 477(4):737-742. PubMed ID: 27363336
[TBL] [Abstract][Full Text] [Related]
19. Triphenylphosphonium derivatives disrupt metabolism and inhibit melanoma growth in vivo when delivered via a thermosensitive hydrogel.
Kloepping KC; Kraus AS; Hedlund DK; Gnade CM; Wagner BA; McCormick ML; Fath MA; Seol D; Lim TH; Buettner GR; Goswami PC; Pigge FC; Spitz DR; Schultz MK
PLoS One; 2020; 15(12):e0244540. PubMed ID: 33378390
[TBL] [Abstract][Full Text] [Related]
20. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
Gao C; Shen Y; Jin F; Miao Y; Qiu X
PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
